Published in Ann Allergy Asthma Immunol on April 13, 2014
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86
Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol (2003) 3.41
One remarkable molecule: filaggrin. J Invest Dermatol (2011) 2.10
The impact of chronic urticaria on the quality of life. Br J Dermatol (1997) 2.08
Filaggrin in atopic dermatitis. J Allergy Clin Immunol (2008) 1.89
The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol (2013) 1.74
New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int (2013) 1.41
BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy (2007) 1.36
Allergic skin diseases. J Allergy Clin Immunol (2009) 1.25
TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol (2002) 1.22
Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy (2010) 1.19
Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol (2005) 1.18
Epidermal barrier in atopic dermatitis. Allergy Asthma Immunol Res (2011) 1.04
Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol (1999) 1.01
Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy (2012) 0.94
Urocanic acid enhances IL-10 production in activated CD4+ T cells. J Immunol (1998) 0.93
Staphylococcus aureus Colonization in Acute and Chronic Skin Lesions of Patients with Atopic Dermatitis. Ann Dermatol (2013) 0.91
Cis-urocanic acid synergizes with histamine for increased PGE2 production by human keratinocytes: link to indomethacin-inhibitable UVB-induced immunosuppression. Photochem Photobiol (1995) 0.91
cis-Urocanic acid stimulates neuropeptide release from peripheral sensory nerves. J Invest Dermatol (2001) 0.87
Histamine induces human beta-defensin-3 production in human keratinocytes. J Dermatol Sci (2009) 0.85
Endogenous prostaglandin E2 modulates calcium-induced differentiation in human skin keratinocytes. Prostaglandins Leukot Essent Fatty Acids (1993) 0.84
cis-Urocanic acid initiates gene transcription in primary human keratinocytes. J Immunol (2008) 0.84
Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria. J Invest Dermatol (2005) 0.82
Topical surfactant-induced pruritus: involvement of histamine released from epidermal keratinocytes. J Pharmacol Exp Ther (2012) 0.80
cis-Urocanic acid enhances prostaglandin E2 release and apoptotic cell death via reactive oxygen species in human keratinocytes. J Invest Dermatol (2011) 0.80
cis-urocanic acid induces mast cell degranulation and release of preformed TNF-alpha: A possible mechanism linking UVB and cis-urocanic acid to immunosuppression of contact hypersensitivity. Skin Pharmacol Appl Skin Physiol (1999) 0.79
Increased histidine decarboxylase expression during in vitro monocyte maturation; a possible role of endogenously synthesised histamine in monocyte/macrophage differentiation. Inflamm Res (2001) 0.79
Histamine enhances the production of human beta-defensin-2 in human keratinocytes. Am J Physiol Cell Physiol (2007) 0.79
The effect of histamine on epidermal outgrowth: its possible dual role as an inhibitor and stimulator. J Invest Dermatol (1981) 0.77